Stock Spotlight: Xero Ltd (ASX:XRO)
About Xero Ltd
Xero Limited, together with its subsidiaries, provides online business solutions for small businesses and their advisors in Australia, New Zealand, the United Kingdom, the United States, and internationally. It offers accounting, payroll, payments and other solutions through its Xero platform. The company also provides Planday, an online employee scheduling software; Hubdoc for bills and receipts; Syft, which creates reports, forecasts, dashboards, and consolidations with AI insights; Melio, a place to pay bills, send invoices, and automate AP/AR workflows; TaxCycle, a tax preparation software for accountants and bookkeepers; and Tickstar, an e-invoicing product. Xero Limited was incorporated in 2006 and is headquartered in Wellington, New Zealand.
Source: EODHD
Key Stats
Key Stats
Source: EODHD. Data as of 19/05/26.
Price Performance
Growth Potential
- Leading provider of cloud-accounting solutions for SMEs & accounting practices with strong market positions in Australia & New Zealand. The Company is now looking to replicate its success in overseas markets such as the U.S. and UK.
- Low underlying churn highlights a strong value proposition, while a structural shift to consumption revenue drives ARPC.
- Management is focused on profitable growth by targeting ‘Rule of 40’ – which is the sum of revenue growth and free cash flow margin should equal 40. Management believes they can double XRO’s FY25 revenue by FY28.
- TAM (including accounting, payments and payroll) is approx. $100bn.
- Launch in new markets and new products, including the integration & monetisation of AI. Accelerated product velocity and a newly defined AI monetization framework.
- Strong management team.
- Upcoming shares buy backs in FY27.
Key Risks
- Increase in churn.
- Currency headwinds due to weakening of NZ$ relative to AUD, USD and Pound.
- Deteriorating sentiment if the economy and IT spending weakens.
- Excessive competition from other established players like Intuit leading to loss of market share.
- Inability to extract higher operational efficiencies as the Company scales up.
- Issues in gaining market share especially in markets with established incumbents.
- Ai systems producing biased or unreliable insights.
- Issues in gaining market share and generating ROI in markets.
Free Stocks Report
Interested in Tech Stocks?
Download our free Tech Stocks Report covering key ASX-listed companies, themes, and analyst insights.
Subscribe to our newsletter
Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.
US-Iran tensions are rattling global markets. Discover how the the latest escalation could affect oil prices, inflation, interest rates and equity markets.
About Medtronic Plc Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland. Source: EODHD Key Stats
About Costco Wholesale Corp Costco Wholesale Corporation, together with its subsidiaries, engages in the operation of membership warehouses in the United States, Puerto Rico, Canada, Mexico, Japan, the United Kingdom, Korea, Australia, Taiwan, China, Spain, France, Iceland, New Zealand, and Sweden. It offers merchandise, including sundries, dry groceries, candies, coolers, freezers, deli, liquor, and tobacco; non-food merchandise comprising appliances, small electronics, health and beauty aids, hardware, lawn and garden, sporting goods, tires, toys and seasonal, automotive, stamps, tickets, apparel, furniture, domestics, housewares, special order kiosks, and jewelry; and fresh food, such as meat, produce, service deli, and bakery products. The company is also involved in warehouse ancillary operations, which include gasoline, pharmacies, optical, food courts, hearing-aid centers, and tire installation centers. In addition, it engages in e-commerce, business centers, travel, and other businesses. The company was formerly known as Costco Companies, Inc. and changed its name to Costco Wholesale Corporation in August 1999. Costco Wholesale Corporation was founded in 1976 and is based in Issaquah, Washington. Source: EODHD Key Stats
About NVIDIA Corp NVIDIA Corporation operates as a data center scale AI infrastructure company. The company operates through two segments, Compute & Networking, and Graphics segments. The Compute & Networking segment provides data center accelerated computing and networking platforms and artificial intelligence solutions and software, and automotive platforms and autonomous and electric vehicle solutions, including software. The Graphics segment offers GeForce GPUs for gaming and PCs; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics. The company's products are used in gaming, professional visualization, data center, and automotive markets. The company sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants worldwide. It has a collaboration with Tech Mahindra Limited to develop artificial intelligence powered telco network operations reasoning agent. The company has a strategic partnership with Lumentum Holdings Inc. to develop optics technologies for AI and data centers. It also has a strategic partnership with Nebius Group N.V. to develop and deploy hyperscale cloud for the artificial intelligence market; and has a strategic partnership with IREN Limited to accelerate deployment of up to 5 gigawatts of infrastructure. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California. Source:EODHD Key Stats
Find out why position sizing matters as much as stock selection and how smart portfolio weighting can improve long-term investment results.
The SpaceX IPO is not just another listing. It may mark the moment public markets begin valuing orbital communications as critical infrastructure.
Anthropic's IPO could become the first major test of generative AI's true value, with implications for technology stocks, capital markets and Australian investors.
Explore how PEG and P/E ratios differ, where each metric performs best, and how investors value high growth companies.
Uranium’s revival is gaining momentum as governments, utilities and investors reposition around nuclear energy and long-term supply shortages.
How geopolitical tensions, military modernisation and AI-driven warfare are fueling a new global defence spending cycle and reshaping defence equities.
